Threshold Haemoglobin Levels and the Prognosis of Stable Coronary Disease: Two New Cohorts and a Systematic Review and Meta-Analysis

English version České info

Background:
Low haemoglobin concentration has been associated with adverse prognosis in patients with angina and myocardial infarction (MI), but the strength and shape of the association and the presence of any threshold has not been precisely evaluated.

Methods and findings:
A retrospective cohort study was carried out using the UK General Practice Research Database. 20,131 people with a new diagnosis of stable angina and no previous acute coronary syndrome, and 14,171 people with first MI who survived for at least 7 days were followed up for a mean of 3.2 years. Using semi-parametric Cox regression and multiple adjustment, there was evidence of threshold haemoglobin values below which mortality increased in a graded continuous fashion. For men with MI, the threshold value was 13.5 g/dl (95% confidence interval [CI] 13.2–13.9); the 29.5% of patients with haemoglobin below this threshold had an associated hazard ratio for mortality of 2.00 (95% CI 1.76–2.29) compared to those with haemoglobin values in the lowest risk range. Women tended to have lower threshold haemoglobin values (e.g, for MI 12.8 g/dl; 95% CI 12.1–13.5) but the shape and strength of association did not differ between the genders, nor between patients with angina and MI. We did a systematic review and meta-analysis that identified ten previously published studies, reporting a total of only 1,127 endpoints, but none evaluated thresholds of risk.

Conclusions:
There is an association between low haemoglobin concentration and increased mortality. A large proportion of patients with coronary disease have haemoglobin concentrations below the thresholds of risk defined here. Intervention trials would clarify whether increasing the haemoglobin concentration reduces mortality.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Threshold Haemoglobin Levels and the Prognosis of Stable Coronary Disease: Two New Cohorts and a Systematic Review and Meta-Analysis. PLoS Med 8(5): e32767. doi:10.1371/journal.pmed.1000439
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000439

Souhrn

Zdroje

1. WeissG

GoodnoughLT

2005 Anemia of chronic disease. N Engl J Med 352 1011 1023

2. AbramsJ

2005 Clinical practice. Chronic stable angina. N Engl J Med 352 2524 2533

3. van der MeerP

GroenveldH

JanuzziJL

van VeldhuisenD

2009 Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95 1309 1314

4. PfefferMA

BurdmannEA

ChenCY

CooperME

de ZeeuwD

2009 A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361 2019 2032

5. SinghAK

SzczechL

TangKL

BarnhartH

SappS

2006 Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 2085 2098

6. SabatineMS

MorrowDA

GiuglianoRP

BurtonPB

MurphySA

2005 Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 2042 2049

7. ArantCB

WesselTR

OlsonMB

Bairey MerzCN

SopkoG

2004 Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 43 2009 2014

8. HemingwayH

RileyRD

AltmanDG

2009 Ten steps towards improving prognosis research. BMJ 339 b4184

9. ReineckeH

TreyT

WellmannJ

HeidrichJ

FobkerM

2003 Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24 2142 2150

10. EnnezatPV

LamblinN

MouquetF

TricotO

QuandalleP

2008 The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction. Eur Heart J 29 1992 1999

11. HerrettE

ThomasSL

SchoonenWM

SmeethL

HallAJ

2010 Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69 4 14

12. HammadTA

McAdamsMA

FeightA

IyasuS

Dal PanG

2008 Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 17 1197 1201

13. NHS Information Authority 2009 The clinical terms version 3 (The Read Codes). Available: http://www.connectingforhealth.nhs.uk/systemsandservices/data/readcodes/index_html. Accessed 22 April 2010

14. NHS Information Centre 2007 The quality and outcomes framework. Available: http://www.ic.nhs.uk/statistics-and-data-collections/audits-and-performance/the-quality-and-outcomes-framework. Accessed 22 April 2010

15. LewisJD

BrensingerC

2004 Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf 13 437 441

16. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 S1 S266

17. SundararajanV

HendersonT

PerryC

MuggivanA

QuanH

2004 New ICD-10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epidemiol 57 1288 1294

18. SelvinE

SteffesMW

ZhuH

MatsushitaK

WagenknechtL

2010 Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362 800 811

19. SungL

HaydenJ

GreenbergML

KorenG

FeldmanBM

2005 Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol 58 261 268

20. RobinsJM

GreenlandS

1986 The role of model selection in causal inference from nonexperimental data. Am J Epidemiol 123 392 402

21. GrambschP

TherneauT

1994 Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 515 5

22. R Development Core Team 2009 R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 3-900051-07-0 Available: http://www.R-project.org. ISBN

23. HemingwayH

HenrikssonM

ChenR

DamantJ

FitzpatrickN

2010 The effectiveness and cost effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health Technol Assess 14

24. DerSimonianR

LairdN

1986 Meta-analysis in clinical trials. Control Clin Trials 7 177 188

25. LumleyT

2009 The rmeta package: meta-analysis. Available: http://CRAN.R-project.org/package=rmeta. Accessed 22 April 2010

26. LipsicE

AsselbergsFW

van der MeerP

TioRA

VoorsAA

2005 Anaemia predicts cardiovascular events in patients with stable coronary artery disease. Neth Heart J 13 254

27. da SilveiraAD

RibeiroRA

RossiniAP

StellaSF

RittaHA

2008 Association of anemia with clinical outcomes in stable coronary artery disease. Coron Artery Dis 19 21 26

28. FathiRB

GurmHS

ChewDP

GuptaR

BhattDL

2005 The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention. Am Heart J 150 1190 1197

29. RajagopalV

GurmHS

BhattDL

LincoffAM

TchengJE

2004 Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol 94 190 192

30. DuffyBK

GurmHS

RajagopalV

GuptaR

EllisSG

2006 Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97 993 996

31. ExaireJE

ButmanSM

EbrahimiR

KleimanNS

HarringtonRA

2006 Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Am Heart J 152 157 163

32. BurrML

HollidayRM

FehilyAM

WhiteheadP

1992 Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 13 166 170

33. MuzzarelliS

PfistererM

2006 Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 152 991 996

34. EggerM

SmithGD

SchneiderM

MinderC

1997 Bias in meta-analysis detected by a simple, graphical test. BMJ 315 629 634

35. KilpatrickGS

HardistyRM

1961 The prevalence of anaemia in the community. a survey of a random sample of the population. Br Med J 1 778 782

36. World Health Organisation 1968 Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405 5 37

37. StrandersI

DiamantM

van GelderRE

SpruijtHJ

TwiskJWR

2004 Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 982 988

38. Di AngelantonioE

DaneshJ

EiriksdottirG

GudnasonV

2007 Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med 4 e270 doi:10.1371/journal.pmed.0040270

39. GagnonDR

ZhangTJ

BrandFN

KannelW

1994 Hematocrit and the risk of cardiovascular disease–the Framingham study: a 34-year follow-up. Am Heart J 127 674 682

40. DaneshJ

CollinsR

PetoR

LoweG

2000 Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 21 515 520

41. FerrucciL

MaggioM

BandinelliS

BasariaS

LauretaniF

2006 Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 166 1380 1388

42. CurtisKK

PruthiRK

FonsecaR

GornetM

2007 Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancer. Urology 70 811

43. CovielloAD

KaplanB

LakshmanKM

ChenT

SinghAB

2008 Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 93 914 919

44. MetivierF

MarchaisSJ

GuerinAP

PannierB

LondonG

2000 Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 15 Suppl 3 14 18

45. EzekowitzJA

McAlisterFA

ArmstrongPW

2003 Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 223 225

46. TangYD

KatzSD

2006 Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113 2454 2461

47. GeislerB

2010 Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents. Expert Opin Biol Ther 10 1209 1216

48. SilverbergDS

WexlerD

IainaA

SteinbruchS

WollmanY

2006 Anemia, chronic renal disease and congestive heart failure–the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 38 295 310

49. MealAG

PringleM

HammersleyV

2000 Time changes in new cases of ischaemic heart disease in general practice. Fam Pract 17 394 400

50. AngelantonioED

SarwarN

PerryP

KaptogeS

Emerging Risk Factors Collaboration 2009 Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302 1993 2000

51. FoxK

GarciaMA

ArdissinoD

BuszmanP

CamiciPG

2006 Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27 1341 1381

52. ParfreyPS

FoleyRN

WittreichBH

SullivanDJ

ZagariMJ

2005 Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16 2180 2189

53. van VeldhuisenDJ

McMurrayJJ

2007 Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 9 110 112